These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27454282)

  • 1. Intracerebroventricular Pain Treatment with Analgesic Mixtures including Ziconotide for Intractable Pain.
    Staquet H; Dupoiron D; Nader E; Menei P
    Pain Physician; 2016 Jul; 19(6):E905-15. PubMed ID: 27454282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian registry on long-term intrathecal ziconotide treatment.
    Raffaeli W; Sarti D; Demartini L; Sotgiu A; Bonezzi C;
    Pain Physician; 2011; 14(1):15-24. PubMed ID: 21267038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal ziconotide for refractory chronic pain.
    Lynch SS; Cheng CM; Yee JL
    Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal ziconotide for refractory pain.
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Jul; 13(7):875-7. PubMed ID: 15212625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment challenges and complications with ziconotide monotherapy in established pump patients.
    Thompson JC; Dunbar E; Laye RR
    Pain Physician; 2006 Apr; 9(2):147-52. PubMed ID: 16703976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziconotide for treatment of severe chronic pain.
    Schmidtko A; Lötsch J; Freynhagen R; Geisslinger G
    Lancet; 2010 May; 375(9725):1569-77. PubMed ID: 20413151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol.
    Dupoiron D; Bore F; Lefebvre-Kuntz D; Brenet O; Debourmont S; Dixmerias F; Buisset N; Lebrec N; Monnin D
    Pain Physician; 2012; 15(5):395-403. PubMed ID: 22996851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model.
    Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A
    J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziconotide.
    Lyseng-Williamson KA; Perry C
    CNS Drugs; 2006; 20(4):331-8; discussion 339-41. PubMed ID: 16599651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
    Wermeling DP; Berger JR
    Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziconotide: can we use it in palliative care?
    Prommer EE
    Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal morphine pump for neuropathic cancer pain: a case report.
    Gogia V; Chaudhary P; Ahmed A; Khurana D; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2012 Aug; 29(5):409-11. PubMed ID: 21868426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer pain.
    O'Neill WM
    Middle East J Anaesthesiol; 1996 Feb; 13(4):373-8. PubMed ID: 8713631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting.
    Adolph MD; Stretanski MF; McGregor JM; Rawn BL; Ross PM; Benedetti C
    Am J Hosp Palliat Care; 2010 Aug; 27(5):326-32. PubMed ID: 20103784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.